Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry

Journal of Proteome Research

Volumn 13, Issue 5, 2014, Pages 2659-2667

  Zhao, Xinjie ^a   Chen, Jihong ^b   Ye, Lei ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

acute graft rejection; HILIC; metabolomics; renal transplantation; RPLC

Indexed keywords

CREATININE; KYNURENINE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; PRASTERONE SULFATE; SPHINGOMYELIN; URIC ACID; BIOLOGICAL MARKER; UNSATURATED FATTY ACID;

ACUTE GRAFT REJECTION; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; ACUTE DISEASE; ADULT; BLOOD; DIFFERENTIAL DIAGNOSIS; FEMALE; GRAFT REJECTION; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; CREATININE; DIAGNOSIS, DIFFERENTIAL; FATTY ACIDS, UNSATURATED; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KYNURENINE; LYSOPHOSPHATIDYLCHOLINES; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHATIDYLCHOLINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPHINGOMYELINS; URIC ACID;

EID: 84899815027     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5001048     Document Type: Article

References (52)

1. Wolfe, R. A.; Ashby, V. B.; Milford, E. L.; Ojo, A. O.; Ettenger, R. E.; Agodoa, L. Y. C.; Held, P. J.; Port, F. K. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant N. Engl. J. Med. 1999, 341 (23) 1725-1730
2. Silberberg, J. S.; Barre, P. E.; Prichard, S. S.; Sniderman, A. D. Impact of left-ventricular hypertrophy on survival in end-stage renal-disease Kidney Int. 1989, 36 (2) 286-290
3. Evans, R. W.; Manninen, D. L.; Garrison, L. P.; Hart, L. G.; Blagg, C. R.; Gutman, R. A.; Hull, A. R.; Lowrie, E. G. The quality of life of patients with end-stage renal-disease N. Engl. J. Med. 1985, 312 (9) 553-559
4. Tantravahi, J.; Womer, K. L.; Kaplan, B. Why hasn't eliminating acute rejection improved graft survival? Annu. Rev. Med. 2007, 58, 369-385
5. Kotanko, P.; Margreiter, R.; Pfaller, W. Urinary N-acetyl-beta-D- glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts Nephron 2000, 84 (3) 228-235
6. Aquino-Dias, E. C.; Joelsons, G.; da Silva, D. M.; Berdichewski, R. H.; Ribeiro, A. R.; Veronose, F. J. V.; Goncalves, L. F.; Manfro, R. C. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function Kidney Int. 2008, 73 (7) 877-884
7. Tatomirovic, Z.; Bokun, R.; Dimitrijevic, J.; Ignjatovic, L.; Aleksic, A.; Hrvacevic, R. Value of urinary cytology findings in the diagnosis of acute renal graft rejection Vojnosanit Pregl. 2003, 60 (1) 35-41
8. Verhelst, X. P. D.; Troisi, R. I.; Colle, I.; Geerts, A.; van Vlierberghe, H. Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review Hepatol. Res. 2013, 43 (2) 165-178
9. Girlanda, R.; Cheema, A. K.; Kaur, P.; Kwon, Y.; Li, A.; Guerra, J.; Matsumoto, C. S.; Zasloff, M.; Fishbein, T. M. Metabolomics of Human Intestinal Transplant Rejection Am. J. Transplant. 2012, 12, S18-S26
10. Legido-Quigley, C.; McDermott, L.; Vilca-Melendez, H.; Murphy, G. M.; Heaton, N.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation Electrophoresis 2011, 32 (15) 2063-2070
11. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-1189
12. Zhao, X.; Peter, A.; Fritsche, J.; Elcnerova, M.; Fritsche, A.; Haering, H.-U.; Schleicher, E. D.; Xu, G.; Lehmann, R. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am. J. Physiol. Endocrinol. Metab. 2009, 296 (2) E384-E393
13. Serkova, N.; Fuller, T. F.; Klawitter, J.; Freise, C. E.; Niemann, C. U. H-1-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants Kidney Int. 2005, 67 (3) 1142-1151
14. Kim, C.-D.; Kim, E.-Y.; Yoo, H.; Lee, J. W.; Ryu, D. H.; Noh, D. W.; Park, S.-H.; Kim, Y.-L.; Hwang, G.-S.; Kwon, T.-H. Metabonomic Analysis of Serum Metabolites in Kidney Transplant Recipients With Cyclosporine A- or Tacrolimus-Based Immunosuppression Transplantation 2010, 90 (7) 748-756
15. Li, L.; Sui, W.; Che, W.; Li, W.; Chen, J.; Li, H.; Tang, D. e.; Li, M.; Dai, Y. 1H NMR-based metabolic profiling of human serum before and after renal transplantation ASAIO J. 2013, 59 (3) 286-93
16. Wang, J.-N.; Zhou, Y.; Zhu, T.-Y.; Wang, X.; Guo, Y.-L. Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS J. Proteome Res. 2008, 7 (8) 3597-3601
17. Wishart, D. S. Metabolomics in monitoring kidney transplants Curr. Opin. Nephrol. Hypertens. 2006, 15 (6) 637-642
18. Chen, J.; Wen, H.; Liu, J.; Yu, C.; Zhao, X.; Shi, X.; Xu, G. Metabonomics study of the acute graft rejection in rat renal transplantation using reversed-phase liquid chromatography and hydrophilic interaction chromatography coupled with mass spectrometry Mol. Biosyst. 2012, 8 (3) 871-878
19. Racusen, L. C.; Solez, K.; Colvin, R. B.; Bonsib, S. M.; Castro, M. C.; Cavallo, T.; Croker, B. P.; Demetris, A. J.; Drachenberg, C. B.; Fogo, A. B.; Furness, P.; Gaber, L. W.; Gibson, I. W.; Glotz, D.; Goldberg, J. C.; Grande, J.; Halloran, P. F.; Hansen, H. E.; Hartley, B.; Hayry, P. J.; Hill, C. M.; Hoffman, E. O.; Hunsicker, L. G.; Lindblad, A. S.; Marcussen, N.; Mihatsch, M. J.; Nadasdy, T.; Nickerson, P.; Olsen, T. S.; Papadimitriou, J. C.; Randhawa, P. S.; Rayner, D. C.; Roberts, I.; Rose, S.; Rush, D.; Salinas-Madrigal, L.; Salomon, D. R.; Sund, S.; Taskinen, E.; Trpkov, K.; Yamaguchi, Y. The Banff 97 working classification of renal allograft pathology Kidney Int. 1999, 55 (2) 713-723
20. Holt, D. W.; Johnston, A.; Marsden, J. T.; Vernillet, L.; Keown, P. A.; Rosano, T. G.; Shaw, L. M.; Rosenthaler, J. Monoclonal-antibodies for radioimmunoassay of cyclosporine-a multicenter comparison of their performance with the sandoz polyclonal radioimmunoassay kit Clin. Chem. 1988, 34 (6) 1091-1096
21. Yin, P.; Peter, A.; Franken, H.; Zhao, X.; Neukamm, S. S.; Rosenbaum, L.; Lucio, M.; Zell, A.; Haering, H.-U.; Xu, G.; Lehmann, R. Preanalytical Aspects and Sample Quality Assessment in Metabolomics Studies of Human Blood Clin. Chem. 2013, 59 (5) 833-845
22. Chen, J.; Zhao, X.; Fritsche, J.; Yin, P.; Schmitt-Kopplin, P.; Wang, W.; Lu, X.; Haring, H. U.; Schleicher, E. D.; Lehmann, R.; Xu, G. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information Anal. Chem. 2008, 80 (4) 1280-1289
23. Bijlsma, S.; Bobeldijk, L.; Verheij, E. R.; Ramaker, R.; Kochhar, S.; Macdonald, I. A.; van Ommen, B.; Smilde, A. K. Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation Anal. Chem. 2006, 78 (2) 567-574
24. Gika, H. G.; Theodoridis, G. A.; Wingate, J. E.; Wilson, I. D. Within-day reproducibility of an HPLC-MS-Based method for metabonomic analysis: Application to human urine J. Proteome Res. 2007, 6 (8) 3291-3303
25. Bhayani, S. B.; Rha, K. H.; Pinto, P. A.; Ong, A. M.; Allaf, M. E.; Trock, B. J.; Jarrett, T. W.; Kavoussi, L. R. Laparoscopic partial nephrectomy: Effect of warm ischemia on serum creatinine J. Urol. 2004, 172 (4) 1264-1266
26. Frumento, G.; Rotondo, R.; Tonetti, M.; Damonte, G.; Benatti, U.; Ferrara, G. B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase J. Exp. Med. 2002, 196 (4) 459-468
27. Taylor, M. W.; Feng, G. S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism FASEB. J. 1991, 5 (11) 2516-2522
28. Terness, P.; Bauer, T. M.; Rose, L.; Dufter, C.; Watzlik, A.; Simon, H.; Opelz, G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites J. Exp. Med. 2002, 196 (4) 447-457
29. Tan, P. H.; Bharath, A. K. Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases Expert Opin. Ther. Targets 2009, 13 (8) 987-1012
30. Uyttenhove, C.; Pilotte, L.; Theate, I.; Stroobant, V.; Colau, D.; Parmentier, N.; Boon, T.; Van den Eynde, B. J. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat. Med. 2003, 9 (10) 1269-1274
31. Hille, R. Structure and function of xanthine oxidoreductase Eur. J. Inorg. Chem. 2006, 10, 1913-1926
32. Meneshian, A.; Bulkley, G. B. The physiology of endothelial xanthine oxidase: From urate catabolism to reperfusion injury to inflammatory signal transduction Microcirculation 2002, 9 (3) 161-175
33. Peglow, S.; Toledo, A. H.; Anaya-Prado, R.; Lopez-Neblina, F.; Toledo-Pereyra, L. H. Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion J. Hepatobiliary Pancreatic Sci. 2011, 18 (2) 137-146
34. Yamakawa, Y.; Takano, M.; Patel, M.; Tien, N.; Takada, T.; Bulkley, G. B. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation Ann. Surg. 2000, 231 (3) 387-398
35. Vaz, F. M.; Wanders, R. J. A. Carnitine biosynthesis in mammals Biochem. J. 2002, 361, 417-429
36. Zeisel, S. H.; da Costa, K.-A. Choline: an essential nutrient for public health Nutr. Rev. 2009, 67 (11) 615-623
37. Menon, V.; Kopple, J. D.; Wang, X.; Beck, G. J.; Collins, A. J.; Kusek, J. W.; Greene, T.; Levey, A. S.; Sarnak, M. J. Effect of a Very Low-Protein Diet on Outcomes: Long-term Follow-up of the Modification of Diet in Renal Disease (MDRD) Study Am. J. Kidney. Dis. 2009, 53 (2) 208-217
38. Nicholson, J. K.; Holmes, E.; Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care Nat. Rev. Microbiol. 2005, 3 (5) 431-438
39. Round, J. L.; Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease Nat. Rev. Immunol. 2009, 9 (5) 313-323
40. Anderson, R.; Vanrensburg, C. E. J.; Myer, M. S. Alpha-tocopherol prevents cyclosporine a-mediated activation of phospholipase a(2) and inhibition of Na+,K+-adenosine triphosphatase-activity in cultured hamster renal tubular cells Toxicol. Appl. Pharmacol. 1994, 125 (2) 176-183
41. Gabryel, B.; Chalimoniuk, M.; Stolecka, A.; Waniek, K.; Langfort, J.; Malecki, A. Inhibition of arachidonic acid release by cytosolic phospholipase A(2) is involved in the antiapoptotic effect of FK506 and cyclosporin A on astrocytes exposed to simulated ischemia in vitro J. Pharmacol. Sci. 2006, 102 (1) 77-87
42. Pena, L. A.; Fuks, Z.; Kolesnick, R. Stress-induced apoptosis and the sphingomyelin pathway Biochem. Pharmacol. 1997, 53 (5) 615-621
43. Ballou, L. R.; Laulederkind, S. J. F.; Rosloniec, E. F.; Raghow, R. Ceramide signalling and the immune response Biochim. Biophys. Acta, Lipids Lipid Metab. 1996, 1301 (3) 273-287
44. Ferraris, R.; Colombatti, G.; Fiorentini, M. T.; Carosso, R.; Arossa, W.; Delapierre, M. Diagnostic-value of serum bile-acids and routine liver-function tests in hepatobiliary diseases-sensitivity, specificity, and predictive value Dig. Dis. Sci. 1983, 28 (2) 129-136
45. Gadaleta, R. M.; van Mil, S. W. C.; Oldenburg, B.; Siersema, P. D.; Klomp, L. W. J.; van Erpecum, K. J. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2010, 1801 (7) 683-692
46. Buford, T. W.; Willoughby, D. S. Impact of DHEA(S) and cortisol on immune function in aging: a brief review Appl. Physiol., Nutr., Metab. 2008, 33 (3) 429-433
47. Khorram, O.; Vu, L.; Yen, S. S. C. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men J. Gerontol., A: Biol. Sci. Med. Sci. 1997, 52 (1) M1-M7
48. Straub, R. H.; Weidler, C.; Demmel, B.; Herrmann, M.; Kees, F.; Schmidt, M.; Scholmerich, J.; Schedel, J. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus Ann. Rheum. Dis. 2004, 63 (8) 961-968
49. Arlt, W.; Callies, F.; van Vlijmen, J. C.; Koehler, I.; Reincke, M.; Bidlingmaier, M.; Huebler, D.; Oettel, M.; Ernst, M.; Schulte, H. M.; Allolio, B. Dehydroepiandrosterone replacement in women with adrenal insufficiency N. Engl. J. Med. 1999, 341 (14) 1013-1020
50. Tritos, N. A. Serum Dehydroepiandrosterone Sulfate in the Diagnosis of Adrenal Insufficiency: Ready for Prime Time? Endocr. Pract. 2011, 17 (2) 167-169
51. Ahmed, H. H.; Morcos, N. Y. S.; Eskander, E. F.; Seoudi, D. M. S.; Shalby, A. B. Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats Exp. Toxicol. Pathol. 2012, 64 (6) 659-664
52. Saponaro, S.; Guarnieri, V.; Pescarmona, G. P.; Silvagno, F. Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptor J. Steroid Biochem. Mol. Biol. 2007, 103 (2) 129-136